MichaelOvermanRPh

PubMed

• Under-reporting of Research Biopsies from Clinical Trials in Oncology.
  Parseghian, C.,Raghav, K.,Wolff, R. A.,Ensor, J. E.,Yao, J. C.,Ellis, L. M.,Tam, A.,Overman, M. J.> ;Clin. Cancer Res.. 2017 Jul 30
• Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, p...
  Overman, M. J.,McDermott, R.,Leach, J. L.,Lonardi, S.,Lenz, H. J.,Morse, M. A.,Desai, J.,Hill, A.,Axelson, M.,Moss, R. A.,Goldberg, M. V.,Cao, Z. A.,Ledeine, J. M.,Mag...> ;Lancet Oncol.. 1900 Jan 01
• Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade.
  Overman, M. J.,Fournier, K.,Hu, C. Y.,Eng, C.,Taggart, M.,Royal, R.,Mansfield, P.,Chang, G. J.> ;Ann. Surg.. 2013 Jun
• Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?
  Alda L Tam, Ravi Murthy, Marshall E Hicks, Michael J Overman> ;Journal of Clinical Oncology. 2013 Jan 1
• Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater
  Jeffrey S Morris, Cathy Eng, Michael J Overman, Gauri R Varadhachary> ;Journal of Clinical Oncology. 2009 Jan 24
• Chemotherapy with 5-Fluorouracil and a Platinum Compound Improves Outcomes in Metastatic Small Bowel Adenocarcinoma
  Michael J Overman, Jeffrey Morris, Jaffer A Ajani, Robert A Wolff> ;Wiley. 2008 Oct 15
• Join now to see all

Journal Articles

• DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway  
  Scott Kopetz, Michael T Tetzlaff, Michael J Overman, Huamin Wang, Clinical Cancer Research